Christina D'Arco, PhD, CMPP

Christina D'Arco, PhD, CMPP has been a member of Linktree for 1 year and joined in October 2024. The social media accounts linked to from Christina D'Arco, PhD, CMPP are: • LinkedIn • Email Besides social media accounts, christinadarco has populated their site with: • Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age • PfaSTer: a machine learning-powered serotype caller for Streptococcus pneumoniae genomes • In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance • Development of a sequence-based in silico OspA typing method for Borrelia burgdorferi sensu lato • Preclinical Evidence for the Protective Capacity of Antibodies Induced by Lyme Vaccine Candidate VLA15 in People • Development and validation of a 6-plex Luminex-based assay for measuring human serum antibodies to group B streptococcus capsular polysaccharides • Calibration of a serum reference standard for Group B streptococcal polysaccharide conjugate vaccine development using surface plasmon resonance - npj Vaccines • Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines - npj Vaccines • A cynomolgus monkey E. coli urinary tract infection model confirms efficacy of new FimH vaccine candidates | Infection and Immunity • Detection of IFN-γ Secretion in Blood Samples Collected Before and After Treatment of Varying Stages of Lyme Disease • Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection • Borrelia burgdorferi-specific IgA in Lyme Disease • Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague • A Statistical Model to Predict Protection Against Infant Respiratory Syncytial Virus Disease Through Maternal Immunization • Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine - npj Vaccines • Structure-based design of an immunogenic, conformationally stabilized FimH antigen for a urinary tract infection vaccine • A novel mucosal vaccine platform for immunization against plague • Mouse monoclonal antibodies against Clostridioides difficile toxins TcdA and TcdB target diverse epitopes for neutralization • Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines - Nature Communications • Genomic characterization of clinical Borrelia burgdorferi sensu lato isolates in the Netherlands over a thirty-year period - BMC Genomics • Analysis of Ibuzatrelvir’s Activity Against SARS-CoV-2 Circulating Variants and In Vitro Resistance Mutations • Vaccines against antimicrobial resistance • Bivalent RSV prefusion F vaccination elicits effective neutralization of contemporary and monoclonal antibody-resistant RSV strains - npj Vaccines • Preclinical immunogenicity of the LP.8.1-adapted BNT162b2 COVID-19 vaccine - npj Vaccines • Antiviral activity of nirmatrelvir against contemporary SARS-CoV-2 Variants • Christina, GSBMS student in the Microbiology and Immunology Ph.D. Program • A human Lyme disease vaccine: two steps forward on the path to prevention • Effects of Methadone Exposure during Development on Avian Brain and Blood Cells • Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid | mBio • Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case-control study • Protective properties of a candidate C-terminal domain OspA vaccine for prevention of Lyme disease • Interlaboratory comparison of a multiplex immunoassay that measures human serum IgG antibodies against six-group B streptococcus polysaccharides